# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-17-020542
Filing Date
2017-04-14
Accepted
2017-04-14 16:01:04
Documents
5
Period of Report
2017-04-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | v464303_pre14a.htm | PRE 14A | 329799
2 | GRAPHIC | pg3img1_pre14a.jpg | GRAPHIC | 8749
3 | GRAPHIC | pg44img1_pre14a.jpg | GRAPHIC | 263001
4 | GRAPHIC | pg45img1_pre14a.jpg | GRAPHIC | 307316
5 | GRAPHIC | pg46img1_pre14a.jpg | GRAPHIC | 121294
| Complete submission text file | 0001144204-17-020542.txt |  | 1296145

Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36598 | Film No.: 17762905
SIC: 2834 Pharmaceutical Preparations